Electromed, Inc. to Participate in the Benchmark Micro Cap Discovery Conference on December 1, 2016
Electromed, Inc. (NYSE MKT:ELMD) today announced that Electromed’s Chief Executive Officer, Kathleen Skarvan, and Chief
Financial Officer, Jeremy Brock, will conduct one-on-one meetings with investors at the Benchmark Company Micro Cap Discovery
Conference on Thursday, December 1, 2016 at The Palmer House Hilton in Chicago.
For more information about The Benchmark Company, LLC's Micro Cap Discovery Conference, visit http://www.benchmarkcompany.com/conference.php.
A copy of Electromed’s latest investor presentation will be available in the Investor Relations section of the company’s website
at: http://www.smartvest.com/electromed/investor-relations/.
About Electromed, Inc.
Electromed, Inc. manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest®
Airway Clearance System, to patients with compromised pulmonary function. The Company is headquartered in New Prague, Minnesota and
was founded in 1992. Further information about Electromed can be found at www.smartvest.com.
Electromed, Inc.
Jeremy Brock, 952-758-9299
Chief Financial Officer
investorrelations@electromed.com
or
The Equity Group Inc.
Kalle Ahl, CFA, 212-836-9614
kahl@equityny.com
or
Devin Sullivan, 212-836-9608
dsullivan@equityny.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20161121005093/en/